JNJ-5207852
CAS No. 398473-34-2
JNJ-5207852( —— )
Catalog No. M20744 CAS No. 398473-34-2
JNJ-5207852 is a novel non-imidazole histamine H3 receptor antagonist with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 31 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 95 | In Stock |
|
| 50MG | 184 | In Stock |
|
| 100MG | 271 | In Stock |
|
| 200MG | 384 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJNJ-5207852
-
NoteResearch use only, not for human use.
-
Brief DescriptionJNJ-5207852 is a novel non-imidazole histamine H3 receptor antagonist with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor.
-
DescriptionJNJ-5207852 is a novel non-imidazole histamine H3 receptor antagonist with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor.
-
In Vitro——
-
In VivoJNJ-5207852 (1-10mg/kg s.c.) increases time spent awake and decreases REM sleep and slow-wave sleep, but fails to have an effect on wakefulness or sleep in H3 receptor knockout mice. The wake promoting effects of this H3 receptor antagonist are not associated with hypermotility. A 4-week daily treatment of mice with JNJ-5207852 (10 mg/kg i.p.) does not lead to a change in body weight. JNJ-5207852 is extensively absorbed after oral administration and reaches high brain levels. Animal Model:Male, Sprague-Dawley ratsweighing 282-334 g.Dosage:3, 10, 30 mg/kg.Administration:S.C. Result:Iincreased time spent awake and decreased REM sleep and slow-wave sleep.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetHistamine Receptor
-
RecptorH3 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number398473-34-2
-
Formula Weight316.48
-
Molecular FormulaC20H32N2O
-
Purity>98% (HPLC)
-
SolubilityDMSO:77.5 mg/mL (244.88 mM)
-
SMILESC(COc1ccc(CN2CCCCC2)cc1)CN1CCCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Esbenshade T A Browman K E Bitner R S et al. The histamine H3 receptor: an attractive target for the treatment of cognitive disorders[J]. 2008 154(6):1166-1181.
molnova catalog
related products
-
Decloxizine
Decloxizine is a H1 receptor antagonist.
-
KSK68
KSK68 is a potent dual sigma-1 and histamine H3 receptor antagonist with potential analgesic activity and high affinity for H3 receptors, sigma-1, sigma-2 receptors.KSK68 can be used in the study of pain related diseases.
-
PF-03654746
PF-03654746 (PF 3654746) is a potent, selective, orally bioactive antagonist of H3 receptor with Ki of 2.3 nM.
Cart
sales@molnova.com